Literature DB >> 3952298

Sclerotic bone metastasis: radiologic-pathologic correlation.

J Aoki, I Yamamoto, M Hino, C Shigeno, N Kitamura, H Itoh, K Torizuka, T Itoh, M Furuta.   

Abstract

Radiographic appearances were correlated with histologic findings in sclerotic bone metastases. For this purpose, undecalcified ground sections were made from lumbar vertebrae obtained at 12 autopsies. The primary tumor sites were the prostate gland in five cases, the breast in three, the lung in two, the stomach in one, and the urinary bladder in one. After Villanueva bone staining and methyl methacrylate embedding, 1-mm-thick ground sections were made for low-kilovoltage contact radiography. In sclerotic bone metastases, new bone is deposited on preexisting trabeculae and in the intertrabecular spaces, forming lacy networks. The radiographic indications of these histologic changes are trabecular thickening, marginal obscurity (the "silhouette" sign), and homogeneous dense sclerotic change. The silhouette sign in bone is a new concept, one that is helpful when the changes in density are not reliable.

Entities:  

Mesh:

Year:  1986        PMID: 3952298     DOI: 10.1148/radiology.159.1.3952298

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Three-dimensional trabecular bone architecture of the lumbar spine in bone metastasis from prostate cancer: comparison with degenerative sclerosis.

Authors:  Tsutomu Tamada; Teruki Sone; Yoshimasa Jo; Shigeki Imai; Yasumasa Kajihara; Masao Fukunaga
Journal:  Skeletal Radiol       Date:  2004-11-16       Impact factor: 2.199

2.  Reactive endosteal bone formation.

Authors:  J Aoki; I Yamamoto; M Hino; N Kitamura; T Sone; H Itoh; K Torizuka
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

3.  Dissociation of bone formation markers in bone metastasis of prostate cancer.

Authors:  M Koizumi; H Maeda; K Yoshimura; T Yamauchi; T Kawai; E Ogata
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis.

Authors:  M Sano; K Kushida; M Takahashi; T Ohishi; K Kawana; M Okada; T Inoue
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.